At 8:35AM, the SGX Nifty was down 23 points at 6,883.
Asian markets except for Japan were trading lower as the emerging crisis in Ukraine continued to weigh on market sentiment. Japan's Nikkei was up 0.7%. Shanghai Composite was down 0.1%, Hang Seng dropped 0.7% and Straits Times was trading 0.4% lower.
Also Read
The Dow Jones ended down 4.3 points at 16,497.35, the broader S&P 500 gained 3 points at 1,878.61 and the tech laden Nasdaq ended up 21 points at 4,148.34.
Stocks in Focus
Cairn India may be under pressure on concerns of lower production guidance.
Muthoot Finance may see some action as the IPP ends today.
Tata Teleservices (Mah) will see some activity on reports that NTT DoCoMo plans to
sell its 26% stake in the company.
Ambuja Cements may see some gains after it recorded a net profit of Rs 520 crore for the quarter ended March, a rise of 6.6 per cent compared with Rs 488 crore in the corresponding quarter last year. The company follows a January-December accounting year. It not only beat group company ACC on profits but surprised analysts, who had expected Ambuja’s adjusted profit (excluding one-off items) to remain flat.
Shashun Pharma will be in action after the board approved allotment of shares and convertible warrants to promoters.
Granules India may firm up on robust March quarter earnings.
Deepak Fertilisers may see some gains after the company's wholly-owned subsidiary on April 23 acquired 0.84% of share capital of Mangalore Chemicals & Fertilisers.
Biocon will react to results which were announced today. On a standalone basis profit for the March 2014 quarter was up at Rs 86.74 crore compared with Rs 38.29 crore in the March 2013 quarter.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)